Spatial genomic heterogeneity within localized, multifocal prostate cancer
-
Published:2015-05-25
Issue:7
Volume:47
Page:736-745
-
ISSN:1061-4036
-
Container-title:Nature Genetics
-
language:en
-
Short-container-title:Nat Genet
Author:
Boutros Paul CORCID, Fraser Michael, Harding Nicholas J, de Borja RichardORCID, Trudel Dominique, Lalonde Emilie, Meng Alice, Hennings-Yeomans Pablo H, McPherson AndrewORCID, Sabelnykova Veronica Y, Zia Amin, Fox Natalie S, Livingstone Julie, Shiah Yu-Jia, Wang Jianxin, Beck Timothy A, Have Cherry L, Chong Taryne, Sam Michelle, Johns Jeremy, Timms Lee, Buchner Nicholas, Wong Ada, Watson John D, Simmons Trent T, P'ng Christine, Zafarana Gaetano, Nguyen Francis, Luo Xuemei, Chu Kenneth C, Prokopec Stephenie D, Sykes Jenna, Dal Pra Alan, Berlin Alejandro, Brown Andrew, Chan-Seng-Yue Michelle A, Yousif Fouad, Denroche Robert E, Chong Lauren C, Chen Gregory M, Jung Esther, Fung Clement, Starmans Maud H W, Chen Hanbo, Govind Shaylan K, Hawley James, D'Costa Alister, Pintilie Melania, Waggott Daryl, Hach Faraz, Lambin PhilippeORCID, Muthuswamy Lakshmi B, Cooper Colin, Eeles Rosalind, Neal David, Tetu Bernard, Sahinalp Cenk, Stein Lincoln D, Fleshner Neil, Shah Sohrab P, Collins Colin C, Hudson Thomas JORCID, McPherson John D, van der Kwast Theodorus, Bristow Robert G
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Mohler, J. et al. NCCN clinical practice guidelines in oncology: prostate cancer. J. Natl. Compr. Canc. Netw. 8, 162–200 (2010). 2. D'Amico, A.V. et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J. Clin. Oncol. 21, 2163–2172 (2003). 3. Buyyounouski, M.K., Pickles, T., Kestin, L.L., Allison, R. & Williams, S.G. Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer. J. Clin. Oncol. 30, 1857–1863 (2012). 4. Villers, A., McNeal, J.E., Freiha, F.S. & Stamey, T.A. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 70, 2313–2318 (1992). 5. Nichol, A.M., Warde, P. & Bristow, R.G. Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy: clinical and translational issues. Cancer 104, 891–905 (2005).
Cited by
397 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|